Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 245 recruiting now early-phase tilt #5 of 28,707 conditions

Depression: early-phase trial registry

245 of 687 indexed Depression trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5 of 28,707 conditions by registered trial count.

687 US clinical trials · 245 currently recruiting · #5 of 28,707 conditions by registered trial count

Depression: 687 US clinical trials tracked, 245 recruiting.

Depression is the subject of 687 registered US clinical trials on ClinicalTrials.gov, 245 of them currently open to new participants. 70 are in Phase 3-4 (later-stage) and 111 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 29 of these trials.

Enrollment posture brief

Registry condition depression

OPEN 245 | RECR 36% | LATE 70 | EARLY 111 | RANK #5 | SPON 29

Nearest open-share peer: Pancreatic Cancer (36% recruiting · 283 trials)

Cancer44.9%Prostate Cancer36.7%Depression (this)36%Hypertension32.2%HIV Infections9.1%
Open-enrollment share among volume-matched conditions near Depression

Depression lists 245 open slots (36% of 687 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depression on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression recruits in line with its size-band peers.

    245 of 687 indexed trials (35.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depression trials is spread across many organizations.

    Massachusetts General Hospital accounts for 29 of 687 trials (4.2%). 231 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depression enrolment sits around 100 participants.

    Median target enrolment is 100 among the 680 trials that report a genuine target (sentinel values excluded). 331 of those (48.7%) plan for fewer than 100 participants.

  4. Depression research is mostly interventional.

    618 interventional and 69 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 141Phase 270Phase 329Phase 441

Open and recent trials

687 total, page 3 of 14

RECRUITING 150 participants

Depression and Driving

Ganesh Babulal

NCT05446805

RECRUITING Phase 1 150 participants

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

National Institute of Mental Health (NIMH)

NCT03065335

RECRUITING Phase 2 150 participants

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

Cedars-Sinai Medical Center

NCT05552053

RECRUITING NA 150 participants

RXWell to Decrease Post-Operative Opioid Use in Total Knee or Hip Arthroplasty

University of Pittsburgh

NCT05658796

RECRUITING NA 150 participants

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

Florida International University

NCT05136703

RECRUITING NA 150 participants

Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Disorders

Viome

NCT06502717

RECRUITING 150 participants

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

San Francisco Veterans Affairs Medical Center

NCT06080646

RECRUITING Phase 2 150 participants

Apimostinel + Automated Neurocognitive Training for Depression

Rebecca Price

NCT06400121

RECRUITING NA 150 participants

Sleep Mechanisms Of Regulating Emotions

Stanford University

NCT06373718

RECRUITING Phase 2 141 participants

Investigation to Understand and Optimize Psilocybin

Charles Raison

NCT06512194

RECRUITING NA 140 participants

Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation

Weill Medical College of Cornell University

NCT06039930

RECRUITING NA 136 participants

Mechanisms of Behavioral Activation (BA)

Emory University

NCT05548244

RECRUITING Phase 3 132 participants

Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care

VA Office of Research and Development

NCT04877197

RECRUITING NA 130 participants

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

Emory University

NCT02604277

RECRUITING Phase 2 128 participants

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)

University of California, San Diego

NCT06273527

RECRUITING NA 128 participants

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Weill Medical College of Cornell University

NCT05925322

RECRUITING NA 120 participants

Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children

New York University

NCT06262178

RECRUITING NA 120 participants

Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction

University of California, San Diego

NCT06678880

RECRUITING NA 120 participants

Researching Heat and Yoga for Mood Enhancement

Massachusetts General Hospital

NCT06094088

RECRUITING NA 120 participants

Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

Massachusetts General Hospital

NCT07082998

RECRUITING NA 120 participants

Stress and Pain in People Living With HIV

Yale University

NCT06784908

RECRUITING NA 120 participants

SilverCloud as a School-Based Intervention for Vulnerable Youth

NYU Langone Health

NCT06004414

RECRUITING NA 120 participants

Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

Yale University

NCT05810259

RECRUITING NA 118 participants

Just-in-Time Training for Youth Mentors

University of Minnesota

NCT07129070

RECRUITING NA 115 participants

WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt

Weill Medical College of Cornell University

NCT05183230

RECRUITING NA 110 participants

Developing Resilience and Anxiety Management Through the Arts

Case Western Reserve University

NCT07033052

RECRUITING Phase 1 108 participants

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

National Institute of Mental Health (NIMH)

NCT05703685

RECRUITING NA 108 participants

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

Boston University Charles River Campus

NCT05624931

RECRUITING Phase 2 108 participants

Pramipexole to Enhance Social Connections

University of California, San Diego

NCT06269146

RECRUITING NA 106 participants

Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care

Portland State University

NCT06019377

RECRUITING Phase 4 103 participants

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

University of North Carolina, Chapel Hill

NCT05282277

RECRUITING Phase 4 100 participants

Identifying and Treating Depression in the Orthopaedic Trauma Population

Wake Forest University Health Sciences

NCT05976347

RECRUITING NA 100 participants

Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD

Texas Tech University

NCT06055322

RECRUITING NA 100 participants

Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners

Massachusetts General Hospital

NCT07220486

RECRUITING Phase 2 100 participants

Psilocybin-Assisted Therapy for Intergenerational Trauma

Rachel Yehuda

NCT06899165

RECRUITING NA 100 participants

Randomized Controlled Trial of a Behavioral Training App

New York University

NCT06447909

RECRUITING NA 100 participants

Fostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST)

Northwestern University

NCT05942469

RECRUITING Phase 2 100 participants

Psilocybin rTMS for Treatment Resistant Depression

University of Texas at Austin

NCT06132178

RECRUITING NA 100 participants

Amplification of Positivity for Alcohol Use

Laureate Institute for Brain Research

NCT06030154

RECRUITING NA 100 participants

Geolocation Positional System (GPS) Experience

University of Miami

NCT05991713

RECRUITING NA 100 participants

Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)

NYU Langone Health

NCT06455527

RECRUITING NA 100 participants

Virtual Patient Groups for Sarcoidosis Associated Fatigue

The Cleveland Clinic

NCT07073963

RECRUITING NA 100 participants

Personalized Mobile Cognitive Behavioral Therapy Application

Weill Medical College of Cornell University

NCT05699525

RECRUITING NA 100 participants

A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD

Weill Medical College of Cornell University

NCT05081596

RECRUITING NA 97 participants

Concurrent TMS-fMRI

Jing Jiang

NCT06633913

RECRUITING NA 96 participants

Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons

University of Wisconsin, Madison

NCT06162624

RECRUITING NA 90 participants

Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

University of Pittsburgh

NCT06963463

RECRUITING NA 90 participants

Mobile Mental Health Stigma Reduction Intervention Among Black Adults

Massachusetts General Hospital

NCT06316804

RECRUITING Phase 4 90 participants

Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients

Texas Tech University Health Sciences Center

NCT06903819

RECRUITING Phase 4 84 participants

Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)

University of Cincinnati

NCT04245748

← Previous Page 3 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 41
Phase 2 70
Phase 3 29
Phase 4 41

Named interventions

Most-linked intervention names on Depression records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
29 trials
Ketamine Drug
11 trials
Escitalopram Drug
11 trials
Psilocybin Drug
8 trials
Placebo Other
8 trials
Sertraline Drug
6 trials
Cognitive Behavioral Therapy Behavioral
5 trials
Duloxetine Drug
5 trials

US sites by state

Facility locations filed on Depression trials. A trial with sites in several states counts in each.

California 116 trials
New York 88 trials
Massachusetts 70 trials
Texas 58 trials
Pennsylvania 54 trials
Florida 49 trials
Maryland 42 trials
North Carolina 38 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depression page

687 registered trials, 245 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depression condition card totals 687 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.